Experimental peptide targets glioblastoma’s most resilient cells
An experimental peptide from Virginia Tech may offer a new way to stop glioblastoma from coming back by disrupting the cancer’s treatment-resistant core.
List view / Grid view
An experimental peptide from Virginia Tech may offer a new way to stop glioblastoma from coming back by disrupting the cancer’s treatment-resistant core.
A Virginia Tech student is investigating new treatments for lupus, an autoimmune disease that affects millions worldwide.
Patients with no detectable FLT3 mutations had the best outcomes after an allogenic hematopoietic cell transplant.
A new approach called reverse metabolomics has discovered molecules that may serve as a biomarker or a therapeutic target for IBD.
The team will receive $2 million over five years to investigate the CA2 brain region for the development of neurological therapies.
A team has shown that the NapA protein, associated with Lyme disease, attracts inflammatory molecules in the body.
A new microfluidic technology has been developed which can profile histone modifications with as few as 100 cells per assay.
A new study has identified a key molecule involved in Lyme arthritis which presents options for preventative therapies.
14 September 2015 | By Victoria White
The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...